ARS Pharmaceuticals Inc. Investor Alert: Learn More Now Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against ARS Pharmaceuticals Inc. (“ARS” or the “Company”) (NASDAQ: SPRY) on behalf of investors that purchased or otherwise acquired ARS securities between March 9, 2026 and June 24, 2026 (the “Class Period”)…. Read MoreJoin Investigation
Datavault AI Inc. Investor Alert: Learn More Now Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Datavault AI Inc. (“Datavault” or the “Company”) (NASDAQ: DVLT) on behalf of investors that purchased or otherwise acquired Datavault securities between September 4, 2024 and October 30, 2025 (the “Class Period”)…. Read MoreJoin Investigation
Avis Budget Group, Inc. Investor Alert: Learn More Now Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Avis Budget Group, Inc. (“Avis” or the “Company”) (NASDAQ: CAR) on behalf of investors that purchased or otherwise acquired Avis securities between February 20, 2025 and April 21, 2026 (the “Class Period”)…. Read MoreJoin Investigation
Capricor Therapeutics, Inc. Investor Alert: Learn More Now Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the “Class Period”)…. Read MoreJoin Investigation
